Table 1 The visit process model for the cSLE study
From: Summarizing the extent of visit irregularity in longitudinal data
Characteristic | Time-Varying | Hazard Ratio | 95% Hazard Ratio Confidence Limits | P-Value | |
|---|---|---|---|---|---|
Disease Activity | Yes | 1.02 | 1.01 | 1.02 | < 0.0001 |
Prednisone (mg) | Yes | 1.02 | 1.01 | 1.02 | < 0.0001 |
Composite Score for Significant Immuno-Suppression | Yes | 1.07 | 1.03 | 1.11 | 0.0010 |
Ethnicity | No | ||||
Asian Vs. Caucasian | – | 1.10 | 1.05 | 1.15 | < 0.0001 |
Black Vs. Caucasian | – | 1.20 | 1.13 | 1.26 | < 0.0001 |
Other Vs. Caucasian | – | 1.08 | 1.02 | 1.14 | 0.0064 |
Age at Diagnosis (Years) | No | 1.02 | 1.01 | 1.03 | < 0.0001 |
Major Organ Involvement Version 1 | No | 1.07 | 1.03 | 1.11 | 0.0012 |